82 related articles for article (PubMed ID: 17099727)
1. Effect of Akt inhibition on scatter factor-regulated gene expression in DU-145 human prostate cancer cells.
Xu J; Gao M; Fan S; Meng Q; Goldberg ID; Abounader R; Ressom H; Laterra JJ; Rosen EM
Oncogene; 2007 May; 26(20):2925-38. PubMed ID: 17099727
[TBL] [Abstract][Full Text] [Related]
2. Identification of genes that modulate sensitivity of U373MG glioblastoma cells to cis-platinum.
Ma Y; Yuan RQ; Fan S; Hu C; Goldberg ID; Laterra JJ; Rosen EM
Anticancer Drugs; 2006 Aug; 17(7):733-51. PubMed ID: 16926624
[TBL] [Abstract][Full Text] [Related]
3. Ras effector pathways modulate scatter factor-stimulated NF-kappaB signaling and protection against DNA damage.
Fan S; Meng Q; Laterra JJ; Rosen EM
Oncogene; 2007 Jul; 26(33):4774-96. PubMed ID: 17297451
[TBL] [Abstract][Full Text] [Related]
4. Role of NF-kappaB signaling in hepatocyte growth factor/scatter factor-mediated cell protection.
Fan S; Gao M; Meng Q; Laterra JJ; Symons MH; Coniglio S; Pestell RG; Goldberg ID; Rosen EM
Oncogene; 2005 Mar; 24(10):1749-66. PubMed ID: 15688034
[TBL] [Abstract][Full Text] [Related]
5. Scatter factor protects epithelial and carcinoma cells against apoptosis induced by DNA-damaging agents.
Fan S; Wang JA; Yuan RQ; Rockwell S; Andres J; Zlatapolskiy A; Goldberg ID; Rosen EM
Oncogene; 1998 Jul; 17(2):131-41. PubMed ID: 9674697
[TBL] [Abstract][Full Text] [Related]
6. Apoptotic susceptibility of cancer cells selected for camptothecin resistance: gene expression profiling, functional analysis, and molecular interaction mapping.
Reinhold WC; Kouros-Mehr H; Kohn KW; Maunakea AK; Lababidi S; Roschke A; Stover K; Alexander J; Pantazis P; Miller L; Liu E; Kirsch IR; Urasaki Y; Pommier Y; Weinstein JN
Cancer Res; 2003 Mar; 63(5):1000-11. PubMed ID: 12615715
[TBL] [Abstract][Full Text] [Related]
7. The cytokine hepatocyte growth factor/scatter factor inhibits apoptosis and enhances DNA repair by a common mechanism involving signaling through phosphatidyl inositol 3' kinase.
Fan S; Ma YX; Wang JA; Yuan RQ; Meng Q; Cao Y; Laterra JJ; Goldberg ID; Rosen EM
Oncogene; 2000 Apr; 19(18):2212-23. PubMed ID: 10822371
[TBL] [Abstract][Full Text] [Related]
8. Targeting the HGF/SF receptor c-met using a hammerhead ribozyme transgene reduces in vitro invasion and migration in prostate cancer cells.
Davies G; Watkins G; Mason MD; Jiang WG
Prostate; 2004 Sep; 60(4):317-24. PubMed ID: 15264243
[TBL] [Abstract][Full Text] [Related]
9. Growth and survival mechanisms associated with perineural invasion in prostate cancer.
Ayala GE; Dai H; Ittmann M; Li R; Powell M; Frolov A; Wheeler TM; Thompson TC; Rowley D
Cancer Res; 2004 Sep; 64(17):6082-90. PubMed ID: 15342391
[TBL] [Abstract][Full Text] [Related]
10. HGF/SF regulates expression of apoptotic genes in MCF-10A human mammary epithelial cells.
Leroy C; Deheuninck J; Reveneau S; Foveau B; Ji Z; Villenet C; Quief S; Tulasne D; Kerckaert JP; Fafeur V
Ann N Y Acad Sci; 2006 Dec; 1090():188-202. PubMed ID: 17384262
[TBL] [Abstract][Full Text] [Related]
11. Gene expression profiling in R-flurbiprofen-treated prostate cancer: R-Flurbiprofen regulates prostate stem cell antigen through activation of AKT kinase.
Zemskova M; Wechter W; Bashkirova S; Chen CS; Reiter R; Lilly MB
Biochem Pharmacol; 2006 Nov; 72(10):1257-67. PubMed ID: 16949054
[TBL] [Abstract][Full Text] [Related]
12. HER-2/neu transcriptionally activates Jab1 expression via the AKT/beta-catenin pathway in breast cancer cells.
Hsu MC; Chang HC; Hung WC
Endocr Relat Cancer; 2007 Sep; 14(3):655-67. PubMed ID: 17914096
[TBL] [Abstract][Full Text] [Related]
13. Profiling of gene expression changes caused by p53 gain-of-function mutant alleles in prostate cancer cells.
Tepper CG; Gregg JP; Shi XB; Vinall RL; Baron CA; Ryan PE; Desprez PY; Kung HJ; deVere White RW
Prostate; 2005 Dec; 65(4):375-89. PubMed ID: 16037992
[TBL] [Abstract][Full Text] [Related]
14. YC-1 inhibits HIF-1 expression in prostate cancer cells: contribution of Akt/NF-kappaB signaling to HIF-1alpha accumulation during hypoxia.
Sun HL; Liu YN; Huang YT; Pan SL; Huang DY; Guh JH; Lee FY; Kuo SC; Teng CM
Oncogene; 2007 Jun; 26(27):3941-51. PubMed ID: 17213816
[TBL] [Abstract][Full Text] [Related]
15. Wilms' tumor 1 gene expression in hepatocellular carcinoma promotes cell dedifferentiation and resistance to chemotherapy.
Perugorria MJ; Castillo J; Latasa MU; Goñi S; Segura V; Sangro B; Prieto J; Avila MA; Berasain C
Cancer Res; 2009 Feb; 69(4):1358-67. PubMed ID: 19190340
[TBL] [Abstract][Full Text] [Related]
16. Altered gene expression pattern in cultured human breast cancer cells treated with hepatocyte growth factor/scatter factor in the setting of DNA damage.
Yuan R; Fan S; Achary M; Stewart DM; Goldberg ID; Rosen EM
Cancer Res; 2001 Nov; 61(21):8022-31. PubMed ID: 11691828
[TBL] [Abstract][Full Text] [Related]
17. cDNA microarray analysis of pigment epithelium-derived factor-regulated gene expression profile in prostate carcinoma cells.
Liu W; Wu Z; Guan M; Lu Y
Int J Urol; 2009 Mar; 16(3):323-8. PubMed ID: 19207613
[TBL] [Abstract][Full Text] [Related]
18. E2F1 Induces tumor cell survival via nuclear factor-kappaB-dependent induction of EGR1 transcription in prostate cancer cells.
Zheng C; Ren Z; Wang H; Zhang W; Kalvakolanu DV; Tian Z; Xiao W
Cancer Res; 2009 Mar; 69(6):2324-31. PubMed ID: 19276347
[TBL] [Abstract][Full Text] [Related]
19. Effects of small interfering RNAs targeting MAPK1 on gene expression profile in HeLa cells as revealed by microarray analysis.
Huang C; Liu LY; Li ZF; Wang P; Ni L; Song LP; Xu DH; Song TS
Cell Biol Int; 2008 Sep; 32(9):1081-90. PubMed ID: 18539490
[TBL] [Abstract][Full Text] [Related]
20. Expression of the prostate transglutaminase (TGase-4) in prostate cancer cells and its impact on the invasiveness of prostate cancer.
Davies G; Ablin RJ; Mason MD; Jiang WG
J Exp Ther Oncol; 2007; 6(3):257-64. PubMed ID: 17552366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]